Sun Pharmaceutical Industries Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹15,299.88 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.71 per cent from ₹14,611.79 crore. This corresponds to a year-on-year *(YoY) growth of 10.46 per cent.
Operating Profit
Operating Profit stands at ₹4,213.58 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.56 per cent from ₹3,954.20 crore. This corresponds to a year-on-year *(YoY) growth of 20.95 per cent.
PBDT
PBDT stands at ₹4,827.96 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.95 per cent from ₹4,312.75 crore. This corresponds to a year-on-year *(YoY) growth of 24.96 per cent.
Profit Before Tax
Profit Before Tax stands at ₹4,089.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.60 per cent from ₹3,537.28 crore. This corresponds to a year-on-year *(YoY) growth of 29.28 per cent.
Net Profit
Net Profit stands at ₹2,901.23 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.07 per cent from ₹2,709.66 crore. This represents a 26.53 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Sun Pharmaceutical Industries Ltd News
Sun Pharmaceutical Industries Ltd Earnings
- YOY
- QOQ
Sun Pharmaceutical Industries Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Sun Pharmaceutical Industries Ltd Research Reports
Sun Pharmaceutical Industries Ltd Financial Reports
Sun Pharmaceutical Industries Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | -0.88% | 0.80% | 6.29% | 9.06% | 22.13% | 21.23% |
| Divi's Lab. | 2.76% | 8.63% | 20.71% | 21.73% | 35.17% | 24.08% |
| Torrent Pharma. | 4.78% | 1.71% | 9.44% | 20.01% | 27.88% | 41.23% |
| Cipla | 0.61% | 4.48% | 1.15% | 10.35% | 12.29% | -2.80% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Dilip S Shanghvi
Executive Director & MD : Kirti Wardhaman Ganorkar
Lead Independent Non Executive Director : Pawan Goenka
Independent Non Exe. Director : Gautam Doshi
Independent Non Exe. Director : Rolf Hoffmann
ED / WTD / CFO / Promoter : AALOK DILIP SHANGHVI
E D & Wholetime Director : Vidhi Shanghvi
Independent Non Exe. Director : Satyavati Berera
Independent Non Exe. Director : Andreas Busch
Company Sec. & Compli. Officer : ANOOP ANJANIKUMAR DESHPANDE